This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Role of brain imaging in early parkinsonism
- MRI-Guided Region-of-Interest Delineation Is Comparable to Manual Delineation in Dopamine Transporter SPECT Quantification in Patients: A Reproducibility Study
- Is Iterative Reconstruction an Alternative to Filtered Backprojection in Routine Processing of Dopamine Transporter SPECT Studies?
- Absolute Quantification in Dopaminergic Neurotransmission SPECT Using a Monte Carlo-Based Scatter Correction and Fully 3-Dimensional Reconstruction
- 123I-5-IA-85380 SPECT Measurement of Nicotinic Acetylcholine Receptors in Human Brain by the Constant Infusion Paradigm: Feasibility and Reproducibility
- Clinical Testing of an Optimized Software Solution for an Automated, Observer-Independent Evaluation of Dopamine Transporter SPECT Studies
- Reproducibility of 99mTc-TRODAT-1 SPECT Measurement of Dopamine Transporters in Parkinson's Disease
- The harsh realities facing the use of SPECT imaging in monitoring disease progression in Parkinson's disease
- Initial Human PET Imaging Studies with the Dopamine Transporter Ligand 18F-FECNT
- Contribution of Scatter and Attenuation Compensation to SPECT Images of Nonuniformly Distributed Brain Activities
- [123I]{beta}-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease
- [123I]{beta}-CIT SPECT imaging assessment of the rate of Parkinson's disease progression